Board MeetingOutcome of Board Meeting
Alkem Labs' Q2 FY26 consolidated revenue surged 17.2% YoY to ₹4,001 Cr.
Alkem Laboratories LimitedALKEM · Filed with the exchange
EBITDA grew 22.3% to ₹920.8 Cr (23% margin), with net profit up 11.1% to ₹765.1 Cr.
Strong growth across India & international markets. #Alkem #Earnings
No comments yet. Be the first.